Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy

Peptides for Biohackers: What's Actually Evidence-Backed in the Longevity Space

Honest evidence assessment of the longevity peptides that dominate biohacker protocols: Epitalon, MOTS-c, SS-31, GHK-Cu, FOXO4-DRI, and the Khavinson bioregulators.

How peptide Targets Peptides for Biohackers & Longevity Protocols

The longevity-peptide landscape has more advocacy than evidence. The honest framing for any of these compounds is that they sit somewhere on a spectrum from 'biologically interesting with thin clinical data' to 'biologically interesting with almost no human data'. None of them have completed a longevity-endpoint RCT in humans, because longevity-endpoint trials in humans are a multi-decade undertaking nobody has funded.

Closest to evidence-supported: GHK-Cu has decades of dermatology and wound-healing data. Its mechanism is real (modulates >4,000 genes), and the cosmetic translation is well-supported. Whether topical or systemic GHK-Cu produces measurable systemic longevity benefit is not established.

Reasonable mechanistic case, thin clinical data: Epitalon has the longest 'longevity peptide' history. Khavinson's group has published cohort data suggesting reduced mortality and cancer incidence in elderly Russian populations on cyclic Epitalon. External replication of those endpoints is essentially absent. Mechanistic premise (telomerase activation, melatonin restoration) is biologically plausible.

MOTS-c and the mitochondrial-derived peptide class have a 'metabolic flexibility' rationale grounded in mtDNA-encoded signaling. Most data is rodent. SS-31 (elamipretide) has more clinical depth in mitochondrial disease but isn't really studied in healthy adults pursuing longevity.

More speculative: FOXO4-DRI is a senolytic peptide with rodent evidence for selective elimination of senescent cells. There is no published human safety or efficacy trial. Use is exploratory.

Where biohackers most often go wrong: stacking 5+ peptides simultaneously and attributing every subjective change to the peptide stack rather than the diet, sleep, and training shifts that usually accompany the experiment. Simple protocols with one variable at a time generate interpretable data; complex stacks generate stories.

Recommended Peptides (10)

5-Amino-1MQ
mitochondrial

5-Amino-1MQ

Research-Grade

A small-molecule NNMT inhibitor (technically not a peptide) grouped with peptides in fat-loss contexts, investigated in preclinical obesity and muscle-aging models.

Epitalon
longevity bioregulator

Epitalon

Research-Grade

A synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on pineal extract Epithalamin — studied by Russian researchers for telomerase, circadian, and longevity endpoints.

FOXO4-DRI
senolytic

FOXO4-DRI

Research-Grade

A D-retro-inverso peptide that disrupts FOXO4-p53 interactions in senescent cells, triggering selective apoptosis. The first peptide-based senolytic — published in Cell (2017) with striking mouse healthspan data.

GHK-Cu (Copper Tripeptide-1)
cosmetic copper

GHK-Cu (Copper Tripeptide-1)

Cosmetic-Grade

A naturally occurring copper-binding tripeptide (Gly-His-Lys) with decades of cosmetic dermatology research in wound healing and skin remodeling.

0.05–0.2% in cosmetic formulationsINCI-listed
Humanin
mitochondrial

Humanin

Research-Grade

A 24-amino-acid mitochondrial-derived peptide (MDP) with cytoprotective, anti-apoptotic, and neuroprotective activity. Encoded within the mitochondrial genome, humanin represents a new class of retrograde signaling molecules.

MOTS-c
mitochondrial

MOTS-c

Research-Grade

A 16-amino-acid peptide encoded in the mitochondrial 12S rRNA — investigated as a metabolic regulator of AMPK signaling and insulin sensitivity.

Sermorelin
growth hormone-secretagogue

Sermorelin

Research-Grade

The first synthetic GHRH analog approved for clinical use — GHRH (1-29) NH₂, the minimum active sequence. Shorter-acting than tesamorelin or CJC-1295.

Previously FDA-approved (Geref, discontinued)Available via compounding in US
SS-31 (Elamipretide)
mitochondrial

SS-31 (Elamipretide)

Research-Grade

A cell-permeable tetrapeptide that targets the inner mitochondrial membrane, stabilizing cardiolipin and improving electron transport chain efficiency — in late-stage clinical trials for mitochondrial and cardiac diseases.

Thymalin
thymic

Thymalin

Research-Grade

A thymic peptide bioregulator developed by the St. Petersburg Institute of Bioregulation and Gerontology, studied in Russian clinical cohorts for immune reconstitution and longevity.

Thymosin α1
immune modulator

Thymosin α1

Zadaxin

A 28-amino-acid thymic peptide approved in 30+ countries (not US) for hepatitis B/C and as an immune adjunct in oncology and infectious disease.

Frequently Asked Questions

Which longevity peptide has the strongest human evidence?
GHK-Cu, but only for the dermatology and wound-healing endpoints it has actually been studied for. For systemic longevity outcomes, no peptide has the kind of evidence that would justify confident claims. Epitalon has the longest history but the publication base is concentrated and not externally replicated.
Are stacks like 'Wolverine' or 'Klow' actually synergistic?
Marketing-named stacks (Wolverine = BPC-157 + TB-500 + GHK-Cu; Klow = ipamorelin + GHK-Cu + others depending on source) reflect rational complementarity but no controlled trial has tested any of these specific combinations. The synergy is theoretical.
Should I cycle Epitalon?
Khavinson protocols are typically 10–20 day courses repeated 1–2× per year, not continuous use. The rationale is that bioregulators 'reset' tissue function rather than maintain a chronic effect. There is no controlled comparison of cyclic vs continuous Epitalon.
Is FOXO4-DRI safe to self-experiment with?
Honestly — no, not in a 'safe' sense that would meet a regulatory bar. There is no human safety trial. Senolytic peptides are mechanistically interesting but the consequences of off-target apoptosis induction in humans are not characterized. This is research peptide territory in the strictest sense.
What labs should I track on a longevity peptide protocol?
Comprehensive metabolic panel, lipid panel, IGF-1, hsCRP, A1C, ApoB, and consider epigenetic age testing (DunedinPACE, GrimAge) at baseline and 6-month intervals. Also track sleep metrics — most peptides claimed to slow aging produce subjective sleep changes that are easier to assess than aging itself.
Should I rely on peptides over rapamycin/metformin/NAD precursors for longevity?
No. Rapamycin and metformin have far larger and more established human evidence bases for healthspan and disease-related endpoints. Peptides should be considered as a supplemental layer, not the foundation of a longevity protocol.

Other peptide Skin Concerns

Peptides for Acne Scars

Topical and systemic peptides that address the collagen disruption, inflammation, and pigmentation c

Peptides for Anti-Aging

Anti-aging is the loosest indication in the peptide literature. 'Longevity' claims are typically ove

Peptides for Athletes & Endurance Training

Which peptides actually have evidence for athletic recovery, what's on the WADA prohibited list, and

Peptides for Brain Fog & Cognitive Clarity

Brain fog — the subjective experience of reduced mental clarity, focus, and processing speed — has m

Peptides for Cognitive Function

The cognitive peptide space is dominated by Russian-developed compounds (Semax, Selank, Cerebrolysin

Peptides for Type 2 Diabetes

GLP-1 receptor agonists are now the most important drug class in T2D management. Here's the evidence

Peptides for Fat Loss

The peptide conversation around fat loss has shifted entirely since the GLP-1 era. This page separat

Peptides for Gut Health

BPC-157 dominates the gut-health peptide conversation, but the evidence is almost entirely preclinic

Peptides for Hair Growth

The peptide hair-growth literature is dominated by GHK-Cu topical and copper peptide complexes. Sign

Peptides for Immune Support

Thymosin Alpha-1 is the strongest-evidence immune peptide, with international marketing authorizatio

Peptides for Injury Recovery

The regenerative peptide category — BPC-157, TB-500, GHK-Cu — has more preclinical signal than most

Peptides for Longevity

Longevity peptides carry the most hype-to-evidence gap in the field. Russian bioregulator peptides (

Peptides for Men Over 40

Testosterone decline, recovery debt, and visceral fat accumulation drive peptide selection past 40.

Peptides for Metabolic Optimization

Metabolic peptides overlap heavily with fat-loss peptides but emphasize different endpoints: insulin

Peptides for Muscle Growth

Hypertrophy-focused peptide protocols cluster around two axes: GH-axis amplification and direct anab

Peptides for PCOS

Polycystic ovary syndrome combines insulin resistance, hyperandrogenism, and disrupted LH/FSH signal

Peptides for Post-Cycle Therapy & HPG Axis Recovery

Gonadorelin, Kisspeptin-10, GHRH analogs in PCT protocols. What's mechanistically real, what's marke

Peptides After Bariatric Surgery

Bariatric surgery (Roux-en-Y bypass, sleeve gastrectomy, duodenal switch) changes peptide pharmacoki

Peptides After Menopause

Bone density, body composition, cardiovascular shift, and skin aging change peptide selection after

Peptides for Post-Surgery Recovery

Surgical recovery creates a defined healing window where peptide interventions are most biologically

Peptides for Sexual Health

Bremelanotide (Vyleesi) is the only FDA-approved peptide for sexual dysfunction — specifically HSDD

Peptides for Skin & Glow

Cosmetic peptides have decades of dermatology research. GHK-Cu, Matrixyl, Argireline, and polynucleo

Peptides for Sleep

The peptide-for-sleep conversation is thinner than marketing implies. DSIP is the only dedicated sle

Peptides for Women Over 40

Hormonal transition, collagen decline, and metabolic shift change which peptides are sensible past 4

Browse All peptide Products

Search

Search across products, blog posts, wiki articles, and more.